Research Associate in Preclinical Neuropathology @ ICN2

Institution: Catalan Institute of Nanoscience and Nanotechnology
Contact e-mail: Ana Belén Avalos (
Published: 09/05/2023
Deadline: 09/17/2023
Link to offer
Offer in PDF

twitter icon
Brief Description:
The Research Associate in Preclinical Neuropathology will undertake research using nanomaterials and neural interface devices used for stimulation, recording and as therapeutic molecule transport systems to the diseased central (CNS) and peripheral nervous system (PNS). Biological and electrophysiological investigations (including cell and tissue analysis using molecular techniques and functional assays) of the implanted devices and nanomaterials using primarily in vivo models will be performed. You will be expected to contribute to the establishment and maintenance of CNS disease models (Parkinson’s, Alzheimer’s, glioblastoma) in collaboration with other investigators within the Nanomedicine Lab, and other collaborative labs. You should be able to interact effectively with researchers from a range of other disciplines to contribute to the programme of research, particularly in the execution and management of in vivo preclinical disease neuropathology, including therapy. The researcher will work closely with the PI (Kostarelos) to validate the appropriate govermental and institutional lisensing for the performance of preclinical disease models in collaboration with the UAB Medical School.

You should hold a PhD in pharmacy, biomedicine, neuroscience, neurobiology, gene therapy of brain disease, neuropharmacology or neurooncology. You should have demonstrable previous neurosurgical experience and familiarity with use of neurodegenerative or neurooncological disease models for therapeutic or diagnostic purposes. Prior experience with in vivo brain cancer models will be particularly preferred. Previous experience in experimental research using devices, biomaterials or nanomaterials and evidence of a developing research publication track record would be advantageous.